Venture Challenge Fall 2013 participant: EdgeLeap partners with 9 million euro research programme to fight heart failure.
EdgeLeap B.V, a data science company providing consultancy and tailored solutions to life science and healthcare…
EdgeLeap B.V, a data science company providing consultancy and tailored solutions to life science and healthcare…
Synaffix BV announced it has entered into a Commercial License Agreement with ADC Therapeutics for its proprietary GlycoConnect™ and HydraSpace™ site-specific antibody-drug…
Recent Comments